CD8A and cancer: To investigate the extent to which these activities is required for the cancer cells to present TAA to CD8+ T cells during viral infection, we treated the virus-infected cells with brefeldin A, a compound that inhibits the transport of molecules through the biosynthetic pathway [34], or proteasome inhibitors MG132 and lactacystin in the presence of IFNγ.